BridgeBio Pharma (BBIO) Ownership
BBIO$76.52-0.84 -1.09%
Market cap$14.91BEnterprise value$16.13BRevenue (TTM)$945.54MMarket positionTop 25%
Score
56
Neutral
Value
39
Quality
30
Growth
98
Ownership data loads after the page opens.
Ownership data loads after the page opens.
BBIO price $76.52 -0.84 -1.09%
Stocklytics score rationale: value 39, quality 30, growth 98.
AI Score 30. BridgeBio Pharma, Inc. has a high price of $74.95 with a market cap of $14.6 billion, but it faces significant challenges with a net profit margin of -60.3% and a price-to-sales ratio of 15.4
Insights · Forecast · Financials · Learn